Results From The Harris Poll and Depression and Bipolar Support Alliance

We're committed to understanding the unique needs of people living with mental illness and supporting disease awareness and education. We know there’s much to be done.

Results from our recent survey conducted with Harris Poll and Depression and Bipolar Support Alliance found an overwhelming majority of patients surveyed with bipolar 1 disorder felt it is a difficult and isolating experience.

Learn More

About AlkermesAlkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

View additional multimedia and more ESG storytelling from Alkermes on 3blmedia.com